Indian School of Business, Hyderabad, India.
Indian Institute of Management, Udaipur, India.
BMC Health Serv Res. 2024 Oct 9;24(1):1206. doi: 10.1186/s12913-024-11560-5.
Hypertension poses a critical threat to health in India, being the predominant risk factor for mortality and disability. With over 70% of outpatient care being provided by the private sector, our study investigated the practices and incentives of private health providers in screening, diagnosing, treating, monitoring, and counseling hypertension patients in rural and peri-urban India. Conducted from April 2020 to February 2021, the qualitative study involved 46 participants, including various healthcare professionals and patients in three Telangana state districts. Analysis revealed a lack of recognition of hypertension's gravity among private providers in these areas, leading to inconsistent screening practices and varied diagnostic thresholds, particularly among rural medical practitioners. Both formal and informal providers lacked standardized protocols and follow-up mechanisms, with limited technical knowledge about hypertension observed, especially among rural practitioners who were often the first point of contact. Drug effectiveness, and incentives from pharmaceutical sales representatives influenced prescribing practices. Diagnostic labs also offered financial incentives for patient referrals. Thus, aligning providers' objectives with patient preferences and public health goals is crucial. To encourage evidence-based hypertension care, the government and NGOs could implement strategies such as tailored incentives, financial rewards, tax benefits, accreditation, and recognition for private healthcare providers. Professional bodies in the private sector should establish programs emphasizing quality assurance and certifications. Future research should focus on designing and testing new models for private sector hypertension service delivery, coupled with targeted interventions to enhance care in rural and peri-urban settings.
在印度,高血压是对健康的重大威胁,是导致死亡和残疾的主要风险因素。由于超过 70%的门诊护理由私营部门提供,我们的研究调查了私营卫生提供者在农村和城乡结合部印度筛查、诊断、治疗、监测和咨询高血压患者方面的做法和激励措施。这项定性研究于 2020 年 4 月至 2021 年 2 月进行,涉及 46 名参与者,包括三个泰伦加纳邦地区的各种医疗保健专业人员和患者。分析显示,这些地区的私营提供者对高血压的严重性认识不足,导致筛查做法不一致,诊断阈值不同,特别是在农村医疗从业者中。正式和非正式的提供者都缺乏标准化的协议和随访机制,对高血压的技术知识有限,特别是在农村从业者中,他们往往是第一个接触点。药物的有效性和来自制药销售代表的激励影响了处方实践。诊断实验室也为患者转诊提供经济激励。因此,将提供者的目标与患者的偏好和公共卫生目标保持一致至关重要。为了鼓励基于证据的高血压护理,政府和非政府组织可以实施一些策略,如定制激励措施、经济奖励、税收优惠、认证和认可私营医疗保健提供者。私营部门的专业机构应制定强调质量保证和认证的计划。未来的研究应侧重于设计和测试新的私营部门高血压服务提供模式,并针对农村和城乡结合部的护理进行有针对性的干预。